Diabetic Neuropathy Market: Need of Treatments on Diabetic Neuropathic to Boost Market Growth
Transparency Market Research (TMR) observes that the global diabetic neuropathy market is competitive and fairly consolidated due to presence of strong players counting for the larger share. Some of the key players operating in the global diabetic neuropathy market includes Johnson & Johnson, Pfizer, Inc., NeuroMetrix, Inc., Boehringer Ingelheim GmbH, Astellas Pharma Inc., GlaxoSmithKline plc, Eli Lilly and Company, Depomed, Inc., Glenmark Pharmaceuticals Ltd, Lupin Limited, and Arbor Pharmaceuticals, LLC. Leading players are adopting the key strategies such as mergers,...
View full press release